BETd-246

CAS No. 2140289-17-2

BETd-246( BETd 246 | BETd246 )

Catalog No. M13420 CAS No. 2140289-17-2

A potent, second-generation BET protein degrader that exhibits superior selectivity, potency and antitumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 485 Get Quote
10MG 710 Get Quote
25MG 1449 Get Quote
50MG 2196 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BETd-246
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, second-generation BET protein degrader that exhibits superior selectivity, potency and antitumor activity.
  • Description
    A potent, second-generation BET protein degrader that exhibits superior selectivity, potency and antitumor activity; completely and selectively depletes BRD2, BRD3 and BRD4 in representative TNBC cell lines with 30-100 nM for 1 h or with 10-30 nM for 3 h incubation; displays strong growth inhibition and apoptosis induction activity in TNBC cell lines with IC50 <1 uM, induces a rapid and time-dependent downregulation of MCL1 protein; decreases BET proteins in xenograft breast tumors and suppress tumor growth in vivo without causing weight loss.
  • In Vitro
    BETd-246 treatment (0-100 nM, 1-3 h) causes a dose-dependent depletion of BRD2, BRD3 and BRD4 in representative TNBC cell lines with 30-100 nM for 1 h or with 10-30 nM for 3 h incubation. BETd-246 (100 nM, 24/48 hours) displays strong growth inhibition and apoptosis induction activity in MDA-MB-468 cell lines. BETd-246 induces a rapid and time-dependent downregulation of MCL1 protein in all the TNBC cell lines evaluated. BETd-246 induces much stronger apoptosis than BETi-211.BETd-246 (100 nM, 24 hours) induces pronounced cell cycle arrest and apoptosis in TNBC cell lines. Cell Proliferation Assay Cell Line:MDA-MB-468 cells Concentration:100 nM Incubation Time:24 or 48 hours Result:Displayed strong growth inhibition and apoptosis induction activity in TNBC cell lines.Cell Cycle Analysis Cell Line:Human TNBC cells Concentration:100 nM Incubation Time:24 hours Result:Induced pronounced cell cycle arrest and apoptosis in TNBC cell lines.Western Blot Analysis Cell Line:Human TNBC cells Concentration:0-100 nM Incubation Time:1-3 hours Result:Caused a dose-dependent depletion of BRD2, BRD3 and BRD4.
  • In Vivo
    BETd-246 (5 mg/kg, IV, 3 times per week for 3 weeks) treatment effectively inhibits WHIM24 tumor growth, similar to the antitumor activity of BETi-211 with higher dosage and more frequently administration. The treatment of 10 mg/kg induces partial tumor regression during treatment without apparent toxicity. BETd-246 has very limited drug exposure in the xenograft tumor tissue in MDA-M-231and MDA-MB-468 models. Animal Model:“Washington Human in Mouse (WHIM)” (PDX) model developed from a patient with treatment-resistant breast cancer (ESRE380Q, PR- and HER2-)).Dosage:5, 10 mg/kg Administration:IV, 3 times per week for 3 weeks.Result:Effectively inhibited WHIM24 tumor growth.
  • Synonyms
    BETd 246 | BETd246
  • Pathway
    PROTACs
  • Target
    PROTAC
  • Recptor
    PROTAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2140289-17-2
  • Formula Weight
    946.035
  • Molecular Formula
    C48H55N11O10
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 200 mg/mL 211.41 mM
  • SMILES
    CCN1C(=CC(=N1)C2CC2)NC3=NC(=NC4=C3C5=CC(=C(C=C5N4)C6=C(ON=C6C)C)OC)C(=O)NCCCOCCOCCOCCCNC7=CC=CC8=C7C(=O)N(C8=O)C9CCC(=O)NC9=O
  • Chemical Name
    4-((3-cyclopropyl-1-ethyl-1H-pyrazol-5-yl)amino)-7-(3,5-dimethylisoxazol-4-yl)-N-(3-(2-(2-(3-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)propoxy)ethoxy)ethoxy)propyl)-6-methoxy-9H-pyrimido[4,5-b]indole-2-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bai L, et al. Cancer Res. 2017 May 1;77(9):2476-2487.
molnova catalog
related products
  • CDK9-PROTAC

    CDK9-PROTAC is a heterobifunctional small molecule PROTAC capable of cereblon mediated proteasomal degradation of CDK9.

  • Azido-PEG1-azide

    Azido-PEG1-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • Hexane-1,6-diyldipho...

    Hexane-1,6-diyldiphosphonic acid (1,6-Hexanebisphosphonic acid) is a PROTAC linker based on the alkyl chain.